Pediatric Transport Safety Collaborative: Adverse Events With Parental Presence During Pediatric Critical Care

Aaisham Ali1, Michael R Miller, Saoirse Cameron1

  • 1From the Department of Pediatrics, Schulich School of Medicine and Dentistry, Western University.

Pediatric Emergency Care
|October 25, 2021
PubMed

Insights

Parental presence during pediatric critical care transport did not significantly impact adverse event rates. This study found no difference in safety outcomes for critically ill children accompanied by parents during interfacility transfers.

Area of Science:

  • Pediatric Critical Care Medicine
  • Transport Medicine
  • Patient Safety

Background:

  • Critically ill children in Canada require interfacility transport to tertiary care centers.
  • Limited data exists on patient safety during pediatric critical care transport with family presence.
  • No Canada-specific data is available on parental accompaniment during critical care transport.

Purpose of the Study:

  • To compare adverse event rates in pediatric critical care transport with and without parental accompaniment.
  • To investigate factors influencing parental accompaniment during transport.
  • To examine the relationship between parental presence and patient outcomes.

Main Methods:

  • Retrospective cohort study of pediatric critical care transports.
  • Included patients under 18 years transported by a specialized team between April 2018 and April 2020.
  • Compared adverse event rates, patient characteristics, and clinical outcomes.

Main Results:

  • 357 transports were analyzed (180 with parental accompaniment, 177 without).
  • Adverse event rates were similar: 49.4% with parental accompaniment vs. 54.8% without (OR, 0.80; P = 0.311).
  • No significant difference in adverse events was observed based on parental presence.

Conclusions:

  • This is the first study to compare adverse event rates and outcomes with and without parental presence during interfacility pediatric critical care transport.
  • Parental presence during these transports was not associated with a significant difference in adverse event rates.
  • Findings suggest parental accompaniment does not compromise patient safety during critical care transport.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
29
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
25
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
33
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
354